209 related articles for article (PubMed ID: 32044038)
1. A significant role of transcription factors E2F in inflammation and tumorigenesis of nasopharyngeal carcinoma.
Liu P; Zhang X; Li Z; Wei L; Peng Q; Liu C; Wu Y; Yan Q; Ma J
Biochem Biophys Res Commun; 2020 Apr; 524(4):816-824. PubMed ID: 32044038
[TBL] [Abstract][Full Text] [Related]
2. Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.
Liu ZF; Yang J; Wei SP; Luo XG; Jiang QS; Chen T; Gong YQ
Kaohsiung J Med Sci; 2020 Nov; 36(11):895-903. PubMed ID: 32668092
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis.
Qin Y; Liao ZW; Luo JY; Wu WZ; Lu AS; Su PX; Lai BQ; Wang XX
Tumour Biol; 2016 Jul; 37(7):9273-83. PubMed ID: 26779625
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXA10-AS Activated by E2F1 Facilitates Proliferation and Migration of Nasopharyngeal Carcinoma Cells Through Sponging miR-582-3p to Upregulate RAB31.
Wang X; Nie P; Zhu D
Am J Rhinol Allergy; 2022 May; 36(3):348-359. PubMed ID: 35072529
[TBL] [Abstract][Full Text] [Related]
5. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
Xie P; Yang JP; Cao Y; Peng LX; Zheng LS; Sun R; Meng DF; Wang MY; Mei Y; Qiang YY; Cao L; Xiang YQ; Luo DH; Yun JP; Huang BJ; Jia LJ; Qian CN
Cell Death Dis; 2017 Jun; 8(6):e2834. PubMed ID: 28569775
[TBL] [Abstract][Full Text] [Related]
6. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
[TBL] [Abstract][Full Text] [Related]
7. E2F3 renders an immunosuppressive tumor microenvironment in nasopharyngeal carcinoma: Involvements of the transcription activation of PRC1 and BIRC5.
Wang Q; Yu Q; Liu Y
Immun Inflamm Dis; 2023 Aug; 11(8):e987. PubMed ID: 37647439
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3.
Zheng ZQ; Li ZX; Zhou GQ; Lin L; Zhang LL; Lv JW; Huang XD; Liu RQ; Chen F; He XJ; Kou J; Zhang J; Wen X; Li YQ; Ma J; Liu N; Sun Y
Cancer Res; 2019 Sep; 79(18):4612-4626. PubMed ID: 31331909
[TBL] [Abstract][Full Text] [Related]
9. E2F1-EP300 co-activator complex potentiates immune escape in nasopharyngeal carcinoma through the mediation of MELK.
Wang Q; Yu Q; Liu Y
Histol Histopathol; 2024 Apr; 39(4):511-523. PubMed ID: 37728155
[TBL] [Abstract][Full Text] [Related]
10. FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.
Li J; Wang W; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Yi M; Xiang B
Cancer Lett; 2019 Feb; 442():1-14. PubMed ID: 30392786
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling.
Zhang X; Yang J; Bian Z; Shi D; Cao Z
Biomed Pharmacother; 2019 May; 113():108713. PubMed ID: 30849642
[TBL] [Abstract][Full Text] [Related]
12. LINC01116 accelerates nasopharyngeal carcinoma progression based on its enhancement on MYC transcription activity.
Xing H; Sun H; Du W
Cancer Med; 2020 Jan; 9(1):269-277. PubMed ID: 31703161
[TBL] [Abstract][Full Text] [Related]
13. GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma.
Nie GH; Luo L; Duan HF; Li XQ; Yin MJ; Li Z; Zhang W
Tumour Biol; 2016 Apr; 37(4):4559-67. PubMed ID: 26503214
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor compensation during mammary gland development in E2F knockout mice.
To B; Andrechek ER
PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434
[TBL] [Abstract][Full Text] [Related]
15. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.
Ke Z; Xie F; Zheng C; Chen D
J Cell Physiol; 2019 Feb; 234(2):1699-1706. PubMed ID: 30070690
[TBL] [Abstract][Full Text] [Related]
16. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
17. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
[TBL] [Abstract][Full Text] [Related]
19. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells.
Niu Z; Liu H; Zhou M; Wang H; Liu Y; Li X; Xiong W; Ma J; Li X; Li G
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):183-91. PubMed ID: 25630654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
